Scientists call on federal regulators to rid US agencies of corporate influence
By Shannon Kelleher
Scientists are calling for the incoming Trump administration to adopt a set of guidelines designed to ensure scientific integrity at federal agencies and loosen corporate influence on regulators charged with protecting Americans’ health.
The recommendations, published Dec. 16, state that the US Environmental Protection Agency (EPA), the US Food and Drug Administration (FDA) and other agencies must eliminate financial and political conflicts of interest from environmental health research, halt industry influence on advisory boards and use the best available science to identify the health risks of toxic chemicals, which are contributing to the rise in chronic diseases such as cancer and diabetes.
Conflicts of interest that undermine the scientific process have resulted in “weakened chemical regulations, increased exposure to harmful chemicals, and greater risks to the health of families, workers, and communities,” the authors concluded.
“Our recommendations will not only strengthen the scientific frameworks of regulatory agencies but also enhance their ability to identify and mitigate toxic chemical exposures, protecting the health of all people who live in the US – especially those who are most susceptible to harm,” Rashmi Joglekar, director of science and policy at the University of California San Francisco Program on Reproductive Health and the Environment (PRHE), said in a press release. PRHE issued the guidelines.
The proposal has been endorsed by at least 48 scientists and public health experts and14 health and environmental organizations. Longer recommendations will be available in early January, said a spokesperson for PRHE.
The EPA and FDA said they plan to review the guidelines.